Three key findings are reshaping clinical understanding of CoQ10 in cardiovascular health. First, CoQ10 functions as the essential electron shuttle in the electron transport chain—not merely as an antioxidant. This primary role directly enables ATP synthesis, the energy currency of cardiac muscle cells. Without adequate CoQ10, the proton gradient necessary for ATP production collapses entirely.
Second, statins reduce CoQ10 by inhibiting the shared metabolic pathway that produces both cholesterol and this vital cofactor. Third, natural age-related decline reduces heart tissue CoQ10 levels by 30 percent by age 40, with further losses in older patients.
These mechanisms suggest clinicians should consider CoQ10 status when evaluating cardiovascular health, particularly in patients on long-term statin therapy. Read the full article on GMJ Newsroom.
Was this article helpful?
